Mark D Alexander

Mark D Alexander

malexander@axinn.com

Mark Alexander’s practice focuses on antitrust, including litigation, merger clearance and counselling; complex commercial litigation; and trademark/copyright litigation. In antitrust, Mark has handled antitrust aspects of dozens of mergers and acquisitions in a host of industries, including wireless and wireline telecommunications, pharmaceuticals, medical devices, oil and gas, oil exploration services, consumer products, mining and minerals, insurance brokerages and business services. 

Mark’s recent merger experience has included Ball’s US$6.85 billion acquisition of Rexam, and Thermo Fisher Scientific’s US$4.2 billion acquisition of FEI and US$1.3 billion acquisition of Affymetrix.